ALLARTA
LIVE

Serial Number

99042716

Owner

Allarta Life Science Inc.

Attorney

Brian Chau

Filing Date

Feb 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ALLARTA Trademark

Serial Number: 99042716

ALLARTA is a trademark filed by Allarta Life Science Inc. on February 18, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Allarta Life Science Inc.

36 Cayley St
Dundas, ON L9H 2E7

Entity Type: 03

Trademark Details

Filing Date

February 18, 2025

Registration Date

Not Registered

Published for Opposition

December 9, 2025

Goods & Services

Chemical agents for scientific research use, namely, macromolecules for the purpose of scientific research about supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants, for use in the scientific research about discovery of new methods regarding implantable medical devices and cell therapies

Medical treatment using cultured cells; stem cell therapy services

Implants consisting of artificial materials for medical use and diagnostic use; coatings sold as an integral component of implantable medical devices, namely, coatings comprised of polymers and chemical compounds

Pharmaceutical preparations for the treatment of endocrine diseases and oncological diseases; stem cells for medical purposes; stem cells and progenitor cells for medical purposes, specifically, for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system; stem cells and progenitor cells for medical purposes, specifically, for use in the production of biologic substances, namely, growth factors and proteins; Hormone replacement therapy preparations; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for use in immunomodulation therapies; surgical implants comprised of living tissues; surgical implants comprising living tissue, namely, surgical implants grown from stem cells; Chemical agents for medical use, namely, macromolecules for the purpose of supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants, for use in the development of implantable medical devices and cell therapies; chemical agents for medical purposes, namely, the coating of implantable medical devices and for encapsulating pharmaceutical agents and cells for the purpose of supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants

Research and development of immune system treatments; Medical and scientific research in the field of stem cell therapy and cell transplantation therapies; Medical research; biopharmaceutical development, research and product evaluation of stem cell-based therapeutics for the treatment of diseases and disorders; Laboratory services for the production of therapeutical cellular products and the active ingredients for cell based therapies

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 3, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 20, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 24, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 23, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 18, 2025 MAFR
NEW APPLICATION ENTERED
Feb 18, 2025 NWAP